Andrew DiNardo
Director of Translational Research, Texas Children’s and Baylor College of Medicine Global TB Program · Baylor College of Medicine
Credentials: · · · · ·
History
Research
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
Nature Immunology · 2021 · 478 citations
Systematic review or meta-analysis · The Lancet Respiratory Medicine · 2015 · 247 citations
Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022
MMWR Morbidity and Mortality Weekly Report · 2022 · 167 citations
42 papers
22 papers
12 papers · 5 as a fellow
8 papers
- JB
5 papers
- ML
4 papers
3 papers
3 papers
Grants
- 2026–2031
Texas Center for AIDS Research
National Institute of Allergy and Infectious Diseases · P30
Project lead · $44.1K · Baylor College of Medicine
- 2023–2028
Post-TB Epigenetic Scars' Impact on Long-Term Inflammation, Immunity and Mortality
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.9M · Baylor College of Medicine
- 2023–2028
Common Post-Infectious Premature Epigenetic Aging
National Institute on Aging · R01
Contact PI · $2.5M · Baylor College of Medicine
- 2019–2024
Persistent DNA Hyper-Methylation of the IFN-γ Signaling Pathway During Tuberculosis
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $946.6K · Baylor College of Medicine
Clinical trials
- 2022–2023
Azacytidine During Anti-tuberculosis Therapy
Principal investigator · Withdrawn · Phase 1, Phase 2
Andrew Dinardo
- 2020–2023
BCG Vaccine for Health Care Workers as Defense Against COVID 19
Principal investigator · Completed · Phase 4
Texas A&M University
- 2025–2026
The Eswatini Study on Neurocognitive Performance in Adolescents Living With HIV
Study director · Not yet recruiting
Eswatini Nazarene Health Institutions